Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome

Cell Proliferation

Volumn 42, Issue 2, 2009, Pages 171-181

  Contestabile, A ^b   Fila, T ^b   Cappellini, A ^c   Bartesaghi, R ^b   Ciani, E ^a,b  

^a Department of Human and General Physiology ^*  (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FIBROBLAST; LIFESPAN; MALE; MENTAL DEFICIENCY; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; SENESCENCE; TRISOMY;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BETA-GALACTOSIDASE; BODY WEIGHT; CELL AGING; CELL CYCLE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA; DOWN SYNDROME; FEMALE; FIBROBLASTS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; POLYPLOIDY; SKIN;

ANIMALIA; MUS;

EID: 62449201452     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00587.x     Document Type: Article

References (75)

1. Sylvester PE (1983) The hippocampus in Down's syndrome. J. Ment. Defic. Res. 27, 227 236.
2. Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA (1990) Brain growth in Down syndrome subjects 15-22 weeks of gestational age and birth to 60 months. Clin. Neuropathol. 9, 181 190.
3. Winter TC, Ostrovsky AA, Komarniski CA, Uhrich SB (2000) Cerebellar and frontal lobe hypoplasia in fetuses with trisomy 21: usefulness as combined US markers. Radiology 214, 533 538.
4. Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL (2001) Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am. J. Psychiatry 158, 1659 1665.
5. Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E (2007) Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17, 665 678.
6. Guidi S, Bonasoni P, Caccarelli C, Santini D, Gualtieri F, Ciani E, Bartesaghi R (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Phatol. 18, 180 197.
7. Rowe RD, Uchida IA (1961) Cardiac malformation in mongolism: a prospective study of 184 mongoloid children. Am. J. Med. 31, 726 735.
8. Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky B, Boss J (1979) Thymic deficiency in Down's syndrome. Pediatrics 63, 80 87.
9. Levy J (1991) The gastrointestinal tract in Down syndrome. Prog. Clin. Biol. Res. 373, 245 256.
10. Allanson JE, O'Hara P, Farkas LG, Nair RC (1993) Anthropometric craniofacial pattern profiles in Down syndrome. Am. J. Med. Genet. 47, 748 752.
11. Roizen NJ, Amarose AP (1993) Hematologic abnormalities in children with Down syndrome. Am. J. Med. Genet. 46, 510 512.
12. Kivivuori SM, Rajantie J, Siimes MA (1996) Peripheral blood cell counts in infants with Down's syndrome. Clin. Genet. 49, 15 19.
13. McElhinney DB, Straka M, Goldmuntz E, Zackai EH (2002) Correlation between abnormal cardiac physical examination and echocardiographic findings in neonates with Down syndrome. Am. J. Med. Genet. 113, 238 241.
14. Bagić I, Verzak Z (2003) Craniofacial anthropometric analysis in Down's syndrome patients. Coll. Antropol. 27, 23 30.
15. Roizen NJ, Patterson D (2003) Down's syndrome. Lancet 361, 1281 1289.
16. Gurbuxani S, Vyas P, Crispino JD (2004) Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 103, 399 406.
17. Cleves MA, Hobbs CA, Cleves PA, Tilford JM, Bird TM, Robbins JM (2007) Congenital defects among liveborn infants with Down syndrome. Birth Defects Res. A Clin. Mol. Teratol. 79, 657 663.
18. Stempfle N, Huten Y, Fredouille C, Brisse H, Nessmann C (1999) Skeletal abnormalities in fetuses with Down's syndrome: a radiographic post-mortem study. Pediatr. Radiol. 29, 682 688.
19. Myrelid A, Gustafsson J, Ollars B, Annerén G (2002) Growth charts for Down's syndrome from birth to 18 years of age. Arch. Dis. Child. 87, 97 103.
20. Styles ME, Cole TJ, Dennis J, Preece MA (2002) New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland. Arch. Dis. Child. 87, 104 108.
21. Melville CA, Cooper SA, McGrother CW, Thorp CF, Collacott R (2005) Obesity in adults with Down syndrome: a case-control study. J. Intellect. Disabil. Res. 49, 125 133.
22. Davisson MT, Schmidt C, Akeson EC (1990) Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog. Clin. Biol. Res. 360, 263 280.
23. Davisson MT, Schmidt C, Reeves RH, Irving NG, Akeson EC, Harris BS, Bronson RT (1993) Segmental trisomy as a mouse model for Down syndrome. Prog. Clin. Biol. Res. 384, 117 133.
24. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 11, 177 184.
25. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT (1998) Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl. Acad. Sci. USA 95, 6256 6261.
26. Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, Huang TT, Epstein CJ (2000) Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48, 606 613.
27. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D, Linehan JM, Sharpe PT, Brandner S, Bliss TV, Henderson DJ, Nizetic D, Tybulewicz VL, Fisher EM (2005) An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309, 2033 2037.
28. 16)65Dn and mouse chromosome 12. Mamm. Genome 16, 79 90.
29. Seregaza Z, Roubertoux PL, Jamon M, Soumireu-Mourat B (2006) Mouse models of cognitive disorders in trisomy 21: a review. Behav. Genet. 36, 387 404.
30. Li Z, Yu T, Morishima M, Pao A, Laduca J, Conroy J, Nowak N, Matsui SIS, Yu Y (2007) Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum. Mol. Genet. 16, 1359 1366.
31. Akeson EC, Lambert JP, Narayanswami S, Gardiner K, Bechtel LJ, Davisson MT (2001) Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet. Cell Genet. 93, 270 276.
32. Gardiner K, Fortna A, Bechtel L, Davisson MT (2003) Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318, 137 147.
33. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat. Rev. Genet. 5, 725 738.
34. Roper RJ, St John HK, Philip J, Lawler A, Reeves RH (2006b) Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172, 437 443.
35. Cefalu JA, Croom WJJ, Eisen EJ, Jones EE, Daniel LR, Taylor IL (1998) Jejunal function and plasma amino acid concentrations in the segmental trisomic Ts65Dn mouse. Growth Dev. Aging 62, 47 59.
36. Richtsmeier JT, Zumwalt A, Carlson EJ, Epstein CJ, Reeves RH (2002) Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am. J. Med. Genet. 107, 317 324.
37. Hill CA, Reeves RH, Richtsmeier JT (2007) Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J. Anat. 210, 394 405.
38. Moore CS (2006) Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model. Mamm. Genome 17, 1005 1012.
39. 16)65Dn mouse, a murine model for human Down's syndrome. J. Immunol. 163, 5399 5410.
40. Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, Crispino JD (2008) Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 111, 767 775.
41. Insausti AM, Megias M, Crespo D, Cruz-Orive LM, Dierssen M, Vallina IF, Insausti R, Florez J (1998) Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome. Neurosci. Lett. 253, 175 178.
42. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000) Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum. Mol. Genet. 9, 195 202.
43. Lorenzi HA, Reeves RH (2006) Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res. 1104, 153 159.
44. Roper RJ, Baxter LL, Saran NG, Klinedinst DK, Beachy PA, Reeves RH (2006a) Defective cerebellar response to mitogenic Hedgehog signaling in Down's syndrome mice. Proc. Natl. Acad. Sci. USA 103, 1452 1456.
45. Chakrabarti L, Galdzicki Z, Haydar TF (2007) Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J. Neurosci. 27, 11483 11495.
46. Contestabile A, Fila T, Bartesaghi R, Ciani E (2006) Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. J. Neurochem. 97, 515 526.
47. Strovel J, Stamberg J, Yarowsky PJ (1999) Interphase FISH for rapid identification of a down syndrome animal model. Cytogenet. Cell Genet. 86, 285 287.
48. Todaro GJ, Green H (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299 313.
49. Crisrofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC (1998) Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc. Natl. Acad. Sci. USA 95, 10614 10619.
50. Takahashi TN, Nowakowski RS, Caviness VS (1993) Cell cycle parameters and patterns of nuclear movement in the neocortical proliferative zone of the fetal mouse. J. Neurosci. 13, 820 833.
51. Lou J, Miller MW (1997) Basic fibroblast growth factor- and platelet-derived growth factor-mediated cell proliferation in B104 neuroblastoma cells: effect of ethanol on cell cycle kinetics. Brain Res. 770, 139 150.
52. Li Z, Lin H, Zhu Y, Wang M, Luo J (2001) Disruption of cell cycle kinetics and cyclin-dependent kinase system by ethanol in cultured cerebellar granule progenitors. Brain Res. Dev. Brain Res. 132, 47 58.
53. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisis J. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363 9367.
54. Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, Bockaert J, Journot L (1997) Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J. 16, 2814 2825.
55. Godard T, Deslandes E, Lebailly P, Vigreux C, Poulain L, Sichel F, Poul JM, Gauduchon P (1999) Comet assay and DNA flow cytometry analysis of staurosporine-induced apoptosis. Cytometry 36, 117 122.
56. Rohme D (1981) Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl. Acad. Sci. USA 8, 5009 5013.
57. Hieter P, Griffiths T (1999) Polyploidy - more is more or less. Science 285, 210 211.
58. Brodsky WY, Uryvaeva IV (1977) Cell polyploidy: its relation to tissue growth and function. Int. Rev. Cytol. 50, 275 332.
59. Wang E, Gundersen D (1984) Increased organization of cytoskeleton accompanying the aging of human fibroblasts in vitro. Exp. Cell Res. 154, 191 202.
60. Cristofalo VJ, Lorenzinia A, Allen RG, Torresa C, Tresinia M (2004) Replicative senescence: a critical review. Mech. Ageing Dev. 125, 827 848.
61. Mason DX, Jackson TJ, Lin AW (2004) Molecular signature of oncogenic ras-induced senescence. Oncogene 23, 9238 9246.
62. Chae S, Yun C, Um H, Lee JH, Cho H (2005) Centrosome amplification and multinuclear phenotypes are Induced by hydrogen peroxide. Exp. Mol. Med. 37, 482 487.
63. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T (1996) Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev. 10, 245 260.
64. Segal DJ, McCoy EE (1974) Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures. J. Cell. Physiol. 83, 85 90.
65. de Haan JB, Cristiano F, Iannello R, Bladier C, Kelner MJ, Kola I (1996) Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum. Mol. Genet. 5, 283 292.
66. de Haan JB, Susil B, Pritchard M, Kola I (2003) An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the 'gene dosage effect' hypothesis. J. Neural Transm. Suppl. 67 83.
67. Harley CB (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256, 271 282.
68. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52, 661 667.
69. de Arruda Cardoso Smith M, Borsatto-Galera B, Feller RI, Goncalves A, Oyama RS, Segato R, Chen E, Carvalheira GM, Filho AS, Burbano RR, Payao SL (2004) Telomeres on chromosome 21 and aging in lymphocytes and gingival fibroblasts from individuals with Down syndrome. J. Oral Sci. 46, 171 177.
70. Brugge KL, Grove GL, Clopton P, Grove MJ, Piacquadio DJ (1993) Evidence for accelerated skin wrinkling among developmentally delayed individuals with Down's syndrome. Mech. Ageing Dev. 70, 213 225.
71. Nakamura E, Tanaka S (1998) Biological ages of adult men and women with Down's syndrome and its changes with aging. Mech. Ageing Dev. 105, 89 103.
72. Madan V, Williams J, Lear JT (2006) Dermatological manifestations of Down's syndrome. Clin. Exp. Dermatol. 31, 623 629.
73. Makrantonaki E, Zouboulis CC (2007) Molecular mechanisms of skin aging: state of the art. Ann. NY Acad. Sci. 1119, 40 50.
74. Raji NS, Rao KS (1998) Trisomy 21 and accelerated aging: DNA-repair parameters in peripheral lymphocytes of Down's syndrome patients. Mech. Ageing Dev. 100, 85 101.
75. Sinha S (2005) Anti-oxidant gene expression imbalance, aging and Down syndrome. Life Sci. 76, 1407 1426.